Hip and knee implants are a big market -- according to Smith & Nephew's (SNN 0.64%) 2013 annual report, worth $14 billion last year. And given that the market has seen strong growth, with Medicare-covered knee replacement surgeries growing by 162% from 1991 to 2010, it's time to consider what investments might be most attractive in this market -- particularly given that most of them pay a dividend. So, Smith & Nephew? Zimmer (NYSE: ZMH)? Stryker (SYK -0.09%)? Johnson & Johnson (JNJ 0.04%)?
In the video below, Motley Fool health care analysts Michael Douglass and David Williamson give their take.
